Activation of an AKT/FOXM1/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancerMeng Li, Chunfu Wu|British Journal of Cancer|2017Cited by 77
PD-L2 drives resistance to EGFR-TKIs: dynamic changes of the tumor immune environment and targeted therapySimeng Wang, Chunfu Wu|Cell Death and Differentiation|2024Cited by 10